Bizarre Patents
An aircraft having vertical takeoff and landing capability provided with at least first and second laterally extending paddle wheels rotatable on a central axis perpendicular to the longitudinal axis of the aircraft fuselage and between its nose and tail.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8138228 | Liquid kelp formulation with or without enhanced shelf life, and method of making A liquid kelp formulation includes an enzyme inactivating component and a preservative to extend the shelf life of the formulation in terms of growth hormones. The formulation can also include a fertilizing additive, and a surfactant. A system is also provided where... | 03/20/2012 |
| 8133920 | Growth hormone-containing formulation and method of use A growth hormone formulation includes an enzyme inactivating component and a preservative. The formulation can also include a fertilizing additive, and a surfactant. The growth hormone can be a natural one such as that found in kelp or a synthetic one or a combinati... | 03/13/2012 |
| 8133919 | Dry fertilizer with growth hormone-containing formulation and methods of use and making A growth hormone formulation includes an enzyme inactivating component and a preservative. The formulation can be incorporated into a dry fertilizer for application using the fertilizer itself or a component of the fertilizer such as one or more of the fillers commo... | 03/13/2012 |
| 7960438 | Use of agomelatine in obtaining medicaments intended for the treatment of generalized anxiety disorder The present invention relates to the use of agomelatine, or N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide, in obtaining medicaments intended for the treatment of Generalized Anxiety Disorder. ... | 06/14/2011 |
| 7432301 | Use of S-nitrosothiol signaling to treat disordered control of breathing The present invention is directed to a method of treating disordered control of breathing including the treatment of apnea and hypoventilation associated with congenital or acquired brain stem abnormalities. Specifically the invention is directed to treating disorde... | 10/07/2008 |
| 7345192 | Reduction of hair growth Compositions including a conjugate of α-difluoromethylornithine can be applied topically to reduce hair growth. ... | 03/18/2008 |
| 7320664 | Reducing discomfort caused by electrical stimulation The invention is directed to a novel method for reducing discomfort caused by transcutaneous stimulation. The novel method includes providing transcutaneous stimulation, reducing the transcutaneous stimulation at a first location, and substantially maintaining the t... | 01/22/2008 |
| 7312244 | Polyamine analog-amino acid conjugates useful as anticancer agents Conjugates in which polyamine analogs are conjugated to an amino acid are provided, as well as compositions comprising these conjugates. Methods of using these conjugates as anticancer treatments are also provided. ... | 12/25/2007 |
| 7232847 | 4-hydroxymethyl-1-aryl-cyclohexylamine compounds The invention relates to 4-hydroxymethyl-1-aryl-cyclohexylamine compounds, methods for their production, pharmaceutical formulations containing such compounds and the use of 4-hydroxymethyl-1-aryl-cyclohexylamine derivatives for producing medicines which are useful,... | 06/19/2007 |
| 7201920 | Methods and compositions for deterring abuse of opioid containing dosage forms This invention relates to an abuse deterrent dosage form of opioid analgesics, wherein an analgesically effective amount of opioid analgesic is combined with a polymer to form a matrix. ... | 04/10/2007 |
| 7189761 | Nitric oxide donor composition and method for treatment of anal disorders A pharmaceutical composition contains a nitric oxide donor and advantageously an optional corticosteroid and/or topical anesthetic. The composition is useful in a method for treating anal disorders such as anal fissure, anal ulcer, hemorrhoidal disease, levator spas... | 03/13/2007 |
| 7176244 | Use of 2-nitropropanol, 2-nitroethane, and 2-nitroethanol for control of microbial pathogens The invention provides a method and compositions for controlling food borne enteric bacterial pathogens in animals. Populations of enteropathogenic bacteria may be substantially reduced or eliminated by treatment of animals with an effective amount of 2-nitropropano... | 02/13/2007 |
| 7157500 | Nitrosylation of protein SH groups and amino acid residues as a therapeutic modality Nitrosylation of proteins and amino acid groups enables selective regulation of protein function, and also endows the proteins and amino acids with additional smooth muscle relaxant and platelet inhibitory capabilities. Thus, the invention relates to novel compounds... | 01/02/2007 |
| 7153256 | Reducing discomfort caused by electrical stimulation The invention is directed to a novel method for reducing discomfort caused by transcutaneous stimulation. The novel method includes providing transcutaneous stimulation, reducing the transcutaneous stimulation at a first location, and substantially maintaining the t... | 12/26/2006 |
| 7151094 | Topical administration of amifostine and related compounds The present invention is directed to methods of treating or protecting mucosal tissue from damage associated with radiation and/or chemotherapeutic treatment of cancers, by the topical application of amifostine and related compounds. These methods avoid the side eff... | 12/19/2006 |
| 7101960 | Process for removing bile salts from a patient and alkylated compositions therefor The invention relates to a method for reducing serum cholesterol in a patient in need thereof and alkylated and crosslinked poly(allylamine) polymers useful in the method. The alkylated and crosslinked poly(allylamine) polymers are crosslinked with epichlorohydrin a... | 09/05/2006 |
| 7045152 | Treating pulmonary disorders with gaseous agent causing repletion of GSNO Pulmonary disorders in which the GSNO pool or glutathione pool in the lung is depleted and where reactive oxygen species in lung are increased, are treated by delivering into the lung as a gas, agent causing repletion or increase of the GSNO pool or protection again... | 05/16/2006 |
| 7015349 | Reduction of hair growth Compositions including a conjugate of α-difluoromethylornithine can be applied topically to reduce hair growth. ... | 03/21/2006 |
| 7012100 | Cell migration inhibiting compositions and methods and compositions for treating cancer Methods for treating an individual having cancer are provided. The method may include administering a cell migration inhibitor and a chemotherapeutic agent to the individual to inhibit migration of cancer cell. Inhibiting cell migration may increase cell division. I... | 03/14/2006 |
| 6929685 | Alkylamine derivatives as antifouling agents The invention relates to methods for preventing the attachment of aquatic organisms to surfaces that are submerged for extension periods of time in water. More particularly, this invention relates to the protection of submerged surfaces with alkylamine derivatives a... | 08/16/2005 |
| 6926660 | Facilitating treatment via magnetic stimulation The invention provides a device, system and method for placing a treatment component on a patient's head. The inventive device includes an attachment frame that attaches the treatment component to the patient's head. The attachment frame also includes a window. A re... | 08/09/2005 |
| 6906050 | Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and MRI diagnosis Substituted porphyrin and azaporphyrin deviations with various substitutents in the 12- and 17-positions of the porphyrin skeleton as pharmaceutical agents for use in photodynamic therapy, MRI diagnosis, and radiodiagnostics. ... | 06/14/2005 |
| 6852686 | Methods for ameliorating icthyosiform skin diseases The present invention relates to the discovery of a method to provide stabilized transglutaminase 1 enzyme, involucrin, and other molecules necessary for the assembly of the cell envelope to skin cells. Novel biological tools, prophylactics, therapeutics, cosmetics,... | 02/08/2005 |
| 6716436 | Cosmetic composition for slimming containing L-arginine, an L-arginine analogue, or one of their derivatives, for topical application A cosmetic composition for slimming which includes, in combination with a cosmetically acceptable excipient, at least one compound having the formula (I) where R1 is a group bound by a peptidic bond and... | 04/06/2004 |
| 6653353 | Cosmetic and personal care compositions Cosmetic or personal care compositions comprise: a hair styling polymer having one or more groups selected from acidic functional groups, anionic groups derived from the acidic functional groups or a mixture of said groups; a partially or fully fluorinate... | 11/25/2003 |
| 6607735 | Method for reducing the appearance of dark circles under the eyes The invention relates to a method for the treatment of the skin around the eyes of a mammal, in particular a method for reducing the puffiness of and the appearance of dark circles on the skin under the eyes. The method comprises topically applying to the... | 08/19/2003 |
| 6605638 | Use of branched chain fatty acids and derivatives thereof for inhibition of P-glycoprotein The invention relates to the use of branched chain fatty acids (BFAs) and their derivatives for inhibition of the activity of P-glycoprotein (P-gp). In particular, the invention relates to the use of BFAs and their derivatives in the treatment of multi-dr... | 08/12/2003 |
| 6605603 | Uses of 1-amino-3-(N,N-dimethylamino)-propylidene-1,1-bisphosphonic acid The present invention relates to novel uses of 1-amino-3-(N,N-dimethylamino)-propylidene-1,1-bisphosphonic acid or any of its soluble salts or any of its hydrates, in particular its use for the manufacture of a medicament for selective modulation of osteo... | 08/12/2003 |
| 6605589 | Cathepsin inhibitors in cancer treatment Embodiments of the present invention provide methods for inhibiting tumor cell growth, or treating cancer cells, in a subject through the administration of a cathepsin inhibitor or inhibitors. Methods for inhibiting inflammatory disease cells as well as o... | 08/12/2003 |
| 6562329 | Method of treating high plasma cholesterol levels A method prevents or treats diseases associated with high plasma cholesterol levels. In addition, this method reduces plasma cholesterol levels. The method comprises administering a lipase inhibitor, e.g. orlistat, and a pharmaceutically acceptable bile a... | 05/13/2003 |
| 6492399 | Pharmaceutical compositions and methods for use Pharmaceutical compositions incorporate aryl substituted olefinic amine compounds. Representative compounds are (3E)-N-methyl-4-[3-(5-nitro-6-aminopyridin)yl]-3-buten-1-amine, (3E)-N-methyl-4-[3-(5-(N-benzylcarboxamido)pyridin)yl]-3-buten-1-amine, (4... | 12/10/2002 |
| 6464764 | Protective agents for wood Solvent-free coating materials and treating agents used as water-based wood or material protective agents containing emulsifiable binding agents, quaternary ammonium compounds and optional additional active agents. The wood or material protective agents a... | 10/15/2002 |
| 6462061 | Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for treatment of dry eye Omega chain modified 15-HETE derivatives and methods of their use for treating dry eye are disclosed.... | 10/08/2002 |
| 6436419 | Antimicrobial treatment of polymers The present invention provides durable and refreshable antimicrobial polymers and methods for preparing the same. In some instances, the polymer is a textile. These textiles have excellent colorfastness and washfastness. The antimicrobial fabrics of this ... | 08/20/2002 |
| 6432390 | Low VOC methyl acetate hair sprays Embodiments relate to reduced VOC hair spray compositions. One composition includes a concentrate and propellant. The concentrate includes 25-45 weight percent alcohol, 30-50 weight percent methyl acetate, 5-15 weight percent resin, 0.2-1.3 weight percent... | 08/13/2002 |
| 6399662 | Method and composition for the treatment of diarrhea and gastrointestinal spasms Anti-diarrheal and/or gastrointestinal anti-spasmodic pharmaceutical compositions containing [A] a polyamine of the formula: R1 --N1 (R2)--(CH2)x--N2 H--Q--N3 H--(CH2)y--N4... | 06/04/2002 |
| 6355690 | Remedy for CAG repeat expansion diseases To elucidate the molecular mechanisms of "gain of toxic function" of expanded polyglutamine stretches in CAG repeat expansion diseases, the inventors established an expression system of full-length and truncated cDNAs for dentatorubral-pallidoluysian atro... | 03/12/2002 |
| 6344191 | Chemical attractants for moths Compositions and lures are described which provide synthetic chemical attractants which function as highly effective attractants for male and female moths, primarily moths of the family Noctuidae. In one aspect, the attractants provide an effective attrac... | 02/05/2002 |
| 6344485 | Method for treating glaucoma Methods of using prostaglandin agonists for the reduction of intraocular pressure, and accordingly glaucoma.... | 02/05/2002 |
| 6344358 | Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property The present invention relates to an agent for the expression of long-term potentiation of synaptic transmission, which contains a compound having a brain somatostatin activation property as an active ingredient and to a screening method of an agent for th... | 02/05/2002 |
